+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
2 Nov 2017

Alembic Pharma acquires US-based drug developer Orbit Labs

Alembic Pharma today announced that it has completed the acquisition of US-based generic drug developer Orbit Laboratories LLC, along with its real estate owned by Okner Realty LLC.

Why Alembic acquires Orbit Laboratories?

  • This acquisition increases Alembic’s US product portfolio with seven approved ANDAs and four ANDAs pending approvals. It also increases Alembic’s breadth and capabilities in the US with a competent R&D team bringing complementary skill sets in soft gelatin based oral solids and oral liquids.

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.